Murphy Sean 4
4 · Poseida Therapeutics, Inc. · Filed Jul 15, 2020
Insider Transaction Report
Form 4
Murphy Sean
Director10% Owner
Transactions
- Conversion
Common Stock
2020-07-14+7,013,918→ 7,013,918 total(indirect: See footnote) - Conversion
Common Stock
2020-07-14+1,168,985→ 8,182,903 total(indirect: See footnote) - Conversion
Common Stock
2020-07-14+690,124→ 8,873,027 total(indirect: See footnote) - Conversion
Common Stock
2020-07-14+315,098→ 9,188,125 total(indirect: See footnote) - Purchase
Common Stock
2020-07-14$16.00/sh+10,000$160,000→ 10,000 total - Conversion
Series A-1 Preferred Stock
2020-07-14−1,457,725→ 0 total(indirect: See footnote)→ Common Stock (1,168,985 underlying) - Conversion
Series B Preferred Stock
2020-07-14−860,585→ 0 total(indirect: See footnote)→ Common Stock (690,124 underlying) - Conversion
Series A Preferred Stock
2020-07-14−8,746,356→ 0 total(indirect: See footnote)→ Common Stock (7,013,918 underlying) - Conversion
Series C Preferred Stock
2020-07-14−392,927→ 0 total(indirect: See footnote)→ Common Stock (315,098 underlying)
Footnotes (2)
- [F1]Each share of the Issuer's Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]Represents shares of common stock issuable upon conversion of preferred stock held by Malin Holdings, a wholly owned subsidiary of Malin Corporation plc ("Malin"), and may be deemed to be beneficially owned by Malin. Malin may be deemed to share voting and investment power over securities held by Malin Holdings. Mr. Murphy currently serves as a member of the leadership team at Malin. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.